|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 201 to 300 out of 382 for Tgm6

<< First    < Previous  |  Next >    Last >>
0.033s

Categories

Hits by Category

Hits by Strain

Type Details Score
Publication
27052162 | J:235087
First Author: Katlinskaya YV
Year: 2016
Journal: Cell Rep
Title: Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression.
Volume: 15
Issue: 1
Pages: 171-80
•
•
•
•
•
Publication
28368402 | J:247888
First Author: Cesarini V
Year: 2017
Journal: Oncogene
Title: Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo.
Volume: 36
Issue: 31
Pages: 4508-4515
•
•
•
•
•
Publication
30914431 | J:276351
First Author: Shurin GV
Year: 2019
Journal: Cancer Res
Title: Melanoma-Induced Reprogramming of Schwann Cell Signaling Aids Tumor Growth.
Volume: 79
Issue: 10
Pages: 2736-2747
•
•
•
•
•
Publication
28433543 | J:243339
First Author: Kim SH
Year: 2017
Journal: J Invest Dermatol
Title: Phenformin Inhibits Myeloid-Derived Suppressor Cells and Enhances theĀ Anti-Tumor Activity of PD-1 Blockade inĀ Melanoma.
Volume: 137
Issue: 8
Pages: 1740-1748
•
•
•
•
•
Publication
33690225 | J:306045
 
First Author: Huang F
Year: 2021
Journal: J Clin Invest
Title: Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.
Volume: 131
Issue: 8
•
•
•
•
•
Publication
30662519 | J:307277
First Author: Lui JW
Year: 2019
Journal: J Cancer
Title: The Efficiency of Verteporfin as a Therapeutic Option in Pre-Clinical Models of Melanoma.
Volume: 10
Issue: 1
Pages: 1-10
•
•
•
•
•
Publication
24746818 | J:277956
First Author: Luo X
Year: 2014
Journal: Cell Rep
Title: Isolation and molecular characterization of circulating melanoma cells.
Volume: 7
Issue: 3
Pages: 645-53
•
•
•
•
•
Publication
33953176 | J:306090
First Author: Di Leo L
Year: 2021
Journal: Nat Commun
Title: Loss of Ambra1 promotes melanoma growth and invasion.
Volume: 12
Issue: 1
Pages: 2550
•
•
•
•
•
Publication
28986383 | J:249341
First Author: Brady DC
Year: 2017
Journal: Cancer Res
Title: Copper Chelation Inhibits BRAFV600E-Driven Melanomagenesis and Counters Resistance to BRAFV600E and MEK1/2 Inhibitors.
Volume: 77
Issue: 22
Pages: 6240-6252
•
•
•
•
•
Publication
30824837 | J:285318
First Author: Long JE
Year: 2019
Journal: Cell Death Differ
Title: Therapeutic resistance and susceptibility is shaped by cooperative multi-compartment tumor adaptation.
Volume: 26
Issue: 11
Pages: 2416-2429
•
•
•
•
•
Publication
25624498 | J:220023
First Author: Perna D
Year: 2015
Journal: Proc Natl Acad Sci U S A
Title: BRAF inhibitor resistance mediated by the AKT pathway in an oncogenic BRAF mouse melanoma model.
Volume: 112
Issue: 6
Pages: E536-45
•
•
•
•
•
Strain
MGI:5752232 | B6J.Cg-Tg(Tyr-cre/ERT2)13Bos Nras<tm1Tyj> Cdkn2a<tm2.1Nesh>
Attribute String: congenic, mutant strain, targeted mutation, transgenic
•
•
•
•
•
Strain
MGI:6148799 | B6.Cg-Tg(Tyr-cre/ERT2)13Bos Nras<tm1.1Nesh>/Mmnc
Attribute String: mutant stock, congenic, transgenic, targeted mutation
•
•
•
•
•
Strain
MGI:5752234 | B6J.Cg-Tg(Tyr-cre/ERT2)13Bos Nras<tm1.1Nesh> Cdkn2a<tm2.1Nesh>
Attribute String: transgenic, targeted mutation, mutant strain, congenic
•
•
•
•
•
Strain
MGI:5645480 | B6.Cg-Tg(Tyr-cre/ERT2)13Bos Nras<tm1.1Nesh> Cdkn2a<tm2.1Nesh>/Nci
Attribute String: congenic, mutant strain, targeted mutation, transgenic
•
•
•
•
•
Strain
MGI:5702888 | C3FeJ.Cg-Tg(Tyr-cre/ERT2)13Bos Gt(ROSA)26Sor<tm1(GNAQ*)Cvrk>/Cvrk
Attribute String: congenic, mutant strain, targeted mutation, transgenic
•
•
•
•
•
Publication
26446958 | J:234067
First Author: Le Gal K
Year: 2015
Journal: Sci Transl Med
Title: Antioxidants can increase melanoma metastasis in mice.
Volume: 7
Issue: 308
Pages: 308re8
•
•
•
•
•
Publication
28642245 | J:244309
First Author: Crawford M
Year: 2017
Journal: Biol Open
Title: A reporter mouse model for in vivo tracing and in vitro molecular studies of melanocytic lineage cells and their diseases.
Volume: 6
Issue: 8
Pages: 1219-1228
•
•
•
•
•
Publication
26645196 | J:234884
First Author: Peng W
Year: 2016
Journal: Cancer Discov
Title: Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy.
Volume: 6
Issue: 2
Pages: 202-16
•
•
•
•
•
Publication
32569596 | J:299503
First Author: Rahman H
Year: 2021
Journal: J Invest Dermatol
Title: Aspirin Protects Melanocytes and Keratinocytes against UVB-Induced DNA Damage InĀ Vivo.
Volume: 141
Issue: 1
Pages: 132-141.e3
•
•
•
•
•
Publication
34400131 | J:312403
First Author: Pandita A
Year: 2021
Journal: Am J Pathol
Title: Intussusceptive Angiogenesis in Human Metastatic Malignant Melanoma.
Volume: 191
Issue: 11
Pages: 2023-2038
•
•
•
•
•
Publication
25313567 | J:217702
First Author: Muinonen-Martin AJ
Year: 2014
Journal: PLoS Biol
Title: Melanoma cells break down LPA to establish local gradients that drive chemotactic dispersal.
Volume: 12
Issue: 10
Pages: e1001966
•
•
•
•
•
Publication
29464040 | J:318893
First Author: Chen HC
Year: 2018
Journal: Oncotarget
Title: Activation of Grm1 expression by mutated BRaf (V600E) in vitro and in vivo.
Volume: 9
Issue: 5
Pages: 5861-5875
•
•
•
•
•
Publication
27210757 | J:235959
First Author: Claps G
Year: 2016
Journal: Cell Rep
Title: A Transcriptionally Inactive ATF2 Variant Drives Melanomagenesis.
Volume: 15
Issue: 9
Pages: 1884-92
•
•
•
•
•
Publication
38711167 | J:354272
First Author: Pastura P
Year: 2024
Journal: Pediatr Blood Cancer
Title: NRAS(Q61R) mutation drives elevated angiopoietin-2 expression in human endothelial cells and a genetic mouse model.
Volume: 71
Issue: 7
Pages: e31032
•
•
•
•
•
Publication
30575721 | J:270317
First Author: Liu S
Year: 2018
Journal: Nat Commun
Title: Loss of Phd2 cooperates with BRAFV600E to drive melanomagenesis.
Volume: 9
Issue: 1
Pages: 5426
•
•
•
•
•
Publication
29343685 | J:260127
First Author: Zhu B
Year: 2018
Journal: Nat Commun
Title: The protective role of DOT1L in UV-induced melanomagenesis.
Volume: 9
Issue: 1
Pages: 259
•
•
•
•
•
Publication
33047672 | J:298687
   
First Author: Ruiz-Vega R
Year: 2020
Journal: Elife
Title: Dynamics of nevus development implicate cell cooperation in the growth arrest of transformed melanocytes.
Volume: 9
•
•
•
•
•
Publication
30787281 | J:274371
First Author: Chen S
Year: 2019
Journal: Nat Commun
Title: Targeting MC1R depalmitoylation to prevent melanomagenesis in redheads.
Volume: 10
Issue: 1
Pages: 877
•
•
•
•
•
Genotype
Genotype
Symbol: Cdkn2a/Cdkn2a Ctnnb1/Ctnnb1 Pten/Pten Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129/Sv * C57BL/6J * FVB * SJL
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cdkn2a/Cdkn2a<+> Kras/Kras<+> Trp53/Trp53<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cdkn2a/Cdkn2a Kras/Kras<+> Trp53/Trp53 Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cdkn2a/Cdkn2a Trp53/Trp53 Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Kras/Kras<+> Trp53/Trp53 Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129P2/OlaHsd * 129S4/SvJae * FVB
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cdkn2a/Cdkn2a Kras/Kras<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129S4/SvJae * C57BL/6 * FVB
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Braf/Braf Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Tyr-cre/ERT2)13Bos/? TgTn(sb-T2/Onc)#Dla/?
Background: involves: 129S6/SvEvTac * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Sox10/Sox10<+> Tg(Tyr-cre/ERT2)13Bos/? Tg(Tyr-NRAS*Q61K)1Bee/?
Background: involves: 129P2/OlaHsd * C57BL/6J * DBA/2 * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Trp53/Trp53 Tg(Tyr-cre/ERT2)13Bos/? Tg(Tyr-NRAS*Q61K)1Bee/?
Background: FVB.Cg-Tg(Tyr-cre/ERT2)13Bos Trp53 Tg(Tyr-NRAS*Q61K)1Bee
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: C3FeJ.Cg-Tg(Tyr-cre/ERT2)13Bos Gt(ROSA)26Sor/Cvrk
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cdkn2a/Cdkn2a Nras/Nras Tg(Tyr-cre/ERT2)13Bos/?
Background: B6J.Cg-Tg(Tyr-cre/ERT2)13Bos Nras Cdkn2a
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cdkn2a/Cdkn2a Nras/Nras Tg(Tyr-cre/ERT2)13Bos/?
Background: B6J.Cg-Tg(Tyr-cre/ERT2)13Bos Nras Cdkn2a
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cdkn2a/Cdkn2a Kras/Kras<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: B6J.Cg-Tg(Tyr-cre/ERT2)13Bos Cdkn2a Kras
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Braf/Braf<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129P2/OlaHsd * FVB
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Braf/Braf Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129P2/OlaHsd * FVB
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Braf/Braf<+> Pten/Pten Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129P2/OlaHsd * 129S1/Sv * FVB
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Braf/Braf<+> Pten/Pten Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Braf/Braf<+> Pten/Pten<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129P2/OlaHsd * 129S1/Sv * FVB
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Ednrb/Ednrb Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6J
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Ednrb/Ednrb Tg(Dct-lacZ)#Ove/? Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Mc1r/Mc1r Tg(Dct-lacZ)#Ove/? Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Pikfyve/Pikfyve Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: C57BL/6 * C57BL/6J
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Braf/Braf<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129P2/OlaHsd * C57BL/6 * FVB
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Cdkn2a/Cdkn2a Nras/Nras<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129 * 129S4/SvJae * 129P2/OlaHsd * C57BL/6 * FVB
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: involves: 129S4/SvJaeSor * C57BL/6 * FVB
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Tyr-cre/ERT2)13Bos/?
Background: B6.Cg-Tg(Tyr-cre/ERT2)13Bos Gt(ROSA)26Sor
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Publication
28869973 | J:252840
First Author: Chen S
Year: 2017
Journal: Nature
Title: Palmitoylation-dependent activation of MC1R prevents melanomagenesis.
Volume: 549
Issue: 7672
Pages: 399-403
•
•
•
•
•
Publication
20550935 | J:167944
First Author: Levy C
Year: 2010
Journal: Cell
Title: Lineage-specific transcriptional regulation of DICER by MITF in melanocytes.
Volume: 141
Issue: 6
Pages: 994-1005
•
•
•
•
•
Publication
32193336 | J:289992
First Author: Sharma S
Year: 2020
Journal: Proc Natl Acad Sci U S A
Title: Targeting the cyclin-dependent kinase 5 in metastatic melanoma.
Volume: 117
Issue: 14
Pages: 8001-8012
•
•
•
•
•
Publication
24019069 | J:206100
First Author: Lee EK
Year: 2013
Journal: Mol Cell Biol
Title: The FBXO4 tumor suppressor functions as a barrier to BRAFV600E-dependent metastatic melanoma.
Volume: 33
Issue: 22
Pages: 4422-33
•
•
•
•
•
Publication
25705882 | J:221902
First Author: Kwong LN
Year: 2015
Journal: J Clin Invest
Title: Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma.
Volume: 125
Issue: 4
Pages: 1459-70
•
•
•
•
•
Publication
26206884 | J:329611
First Author: Fufa TD
Year: 2015
Journal: Hum Mol Genet
Title: Genomic analysis reveals distinct mechanisms and functional classes of SOX10-regulated genes in melanocytes.
Volume: 24
Issue: 19
Pages: 5433-50
•
•
•
•
•
Publication
20048081 | J:155731
First Author: Held MA
Year: 2010
Journal: Cancer Res
Title: Characterization of melanoma cells capable of propagating tumors from a single cell.
Volume: 70
Issue: 1
Pages: 388-97
•
•
•
•
•
Publication
30355677 | J:271155
First Author: Hill KS
Year: 2019
Journal: Mol Cancer Res
Title: PTPN11 Plays Oncogenic Roles and Is a Therapeutic Target for BRAF Wild-Type Melanomas.
Volume: 17
Issue: 2
Pages: 583-593
•
•
•
•
•
Publication
32238882 | J:335346
First Author: Uka R
Year: 2020
Journal: Oncogene
Title: Temporal activation of WNT/Ī²-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growth.
Volume: 39
Issue: 20
Pages: 4132-4154
•
•
•
•
•
Publication
22698401 | J:189285
First Author: Liu W
Year: 2012
Journal: Cancer Cell
Title: LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma.
Volume: 21
Issue: 6
Pages: 751-64
•
•
•
•
•
Publication
28368416 | J:247693
First Author: Schaefer SM
Year: 2017
Journal: Oncogene
Title: Sox2 is dispensable for primary melanoma and metastasis formation.
Volume: 36
Issue: 31
Pages: 4516-4524
•
•
•
•
•
Publication
25609585 | J:219707
 
First Author: Zingg D
Year: 2015
Journal: Nat Commun
Title: The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors.
Volume: 6
Pages: 6051
•
•
•
•
•
Publication
26450788 | J:231490
First Author: Rai K
Year: 2015
Journal: Cancer Discov
Title: Dual Roles of RNF2 in Melanoma Progression.
Volume: 5
Issue: 12
Pages: 1314-27
•
•
•
•
•
Strain
MGI:6792067 | STOCK Tg(Tyr-cre/ERT2)13Bos Gt(ROSA)26Sor<tm1(GNAQ*)Cvrk>/Gt(ROSA)26Sor<tm1Sor>/Cvrk
Attribute String: mutant stock, targeted mutation, transgenic
•
•
•
•
•
Publication
23935512 | J:213046
First Author: Harris ML
Year: 2013
Journal: PLoS Genet
Title: A dual role for SOX10 in the maintenance of the postnatal melanocyte lineage and the differentiation of melanocyte stem cell progenitors.
Volume: 9
Issue: 7
Pages: e1003644
•
•
•
•
•
Publication
26113083 | J:225597
First Author: Huang JL
Year: 2015
Journal: Cancer Res
Title: Oncogenic G Protein GNAQ Induces Uveal Melanoma and Intravasation in Mice.
Volume: 75
Issue: 16
Pages: 3384-97
•
•
•
•
•
Publication
25584893 | J:218894
First Author: Damsky W
Year: 2015
Journal: Cancer Cell
Title: mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation.
Volume: 27
Issue: 1
Pages: 41-56
•
•
•
•
•
Publication
28192409 | J:243383
First Author: Tonks ID
Year: 2017
Journal: Oncogene
Title: Melanocyte transformation requires complete loss of all pocket protein function via a mechanism that mitigates the need for MAPK pathway activation.
Volume: 36
Issue: 26
Pages: 3789-3795
•
•
•
•
•
Publication
29438700 | J:257785
First Author: Yu Y
Year: 2018
Journal: Cancer Cell
Title: Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma.
Volume: 33
Issue: 2
Pages: 322-336.e8
•
•
•
•
•
Strain
MGI:4948437 | B6.Cg-Tg(Tyr-cre/ERT2)13Bos Braf<tm1Mmcm> Pten<tm1Hwu>/BosJ
Attribute String: transgenic, targeted mutation, mutant strain, congenic
•
•
•
•
•
Publication
34689087 | J:312866
 
First Author: Le HH
Year: 2021
Journal: EBioMedicine
Title: Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells.
Volume: 73
Pages: 103646
•
•
•
•
•
Publication
28376192 | J:245620
 
First Author: Bonet C
Year: 2017
Journal: J Natl Cancer Inst
Title: Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression.
Volume: 109
Issue: 8
•
•
•
•
•
Publication
31449725 | J:309201
First Author: Zhai Y
Year: 2020
Journal: Pigment Cell Melanoma Res
Title: Differences in tumor initiation and progression of melanoma in the BrafCA ;Tyr-CreERT2;Ptenf/f model between male and female mice.
Volume: 33
Issue: 1
Pages: 119-121
•
•
•
•
•
Publication
30209062 | J:286512
First Author: Zhao F
Year: 2018
Journal: Cancer Immunol Res
Title: Stromal Fibroblasts Mediate Anti-PD-1 Resistance via MMP-9 and Dictate TGFĪ² Inhibitor Sequencing in Melanoma.
Volume: 6
Issue: 12
Pages: 1459-1471
•
•
•
•
•
Publication
34597611 | J:333928
First Author: Chhabra G
Year: 2022
Journal: J Invest Dermatol
Title: Antimelanoma Effects of Concomitant Inhibition of SIRT1 and SIRT3 in Braf(V600E)/Pten(NULL) Mice.
Volume: 142
Issue: 4
Pages: 1145-1157.e7
•
•
•
•
•
Publication
32620791 | J:293364
First Author: Ishak Gabra MB
Year: 2020
Journal: Nat Commun
Title: Dietary glutamine supplementation suppresses epigenetically-activated oncogenic pathways to inhibit melanoma tumour growth.
Volume: 11
Issue: 1
Pages: 3326
•
•
•
•
•
Publication
29179997 | J:253811
 
First Author: RodrĆ­guez CI
Year: 2018
Journal: Cancer Lett
Title: Elevated cyclic AMP levels promote BRAFCA/Pten-/- mouse melanoma growth but pCREB is negatively correlated with human melanoma progression.
Volume: 414
Pages: 268-277
•
•
•
•
•
Publication
28111070 | J:239513
First Author: Spitzer MH
Year: 2017
Journal: Cell
Title: Systemic Immunity Is Required for Effective Cancer Immunotherapy.
Volume: 168
Issue: 3
Pages: 487-502.e15
•
•
•
•
•
Publication
38640236 | J:348259
First Author: Niu L
Year: 2024
Journal: Sci Adv
Title: Noncovalently particle-anchored cytokines with prolonged tumor retention safely elicit potent antitumor immunity.
Volume: 10
Issue: 16
Pages: eadk7695
•
•
•
•
•
Publication
26679841 | J:227690
First Author: Ferretti R
Year: 2016
Journal: Genes Dev
Title: BMI1 induces an invasive signature in melanoma that promotes metastasis and chemoresistance.
Volume: 30
Issue: 1
Pages: 18-33
•
•
•
•
•
Publication
28851815 | J:249476
First Author: RodrĆ­guez CI
Year: 2017
Journal: Mol Cancer Res
Title: EPAC-RAP1 Axis-Mediated Switch in the Response of Primary and Metastatic Melanoma to Cyclic AMP.
Volume: 15
Issue: 12
Pages: 1792-1802
•
•
•
•
•
Publication
36672468 | J:332804
 
First Author: Mikheil D
Year: 2023
Journal: Cancers (Basel)
Title: Notch Signaling Suppresses Melanoma Tumor Development in BRAF/Pten Mice.
Volume: 15
Issue: 2
•
•
•
•
•
Publication
35385746 | J:328646
First Author: Jahid S
Year: 2022
Journal: Cell Rep
Title: Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancer.
Volume: 39
Issue: 1
Pages: 110641
•
•
•
•
•
Publication
30664687 | J:295160
First Author: Bagati A
Year: 2019
Journal: Oncogene
Title: KLF9-dependent ROS regulate melanoma progression in stage-specific manner.
Volume: 38
Issue: 19
Pages: 3585-3597
•
•
•
•
•
Publication
29643229 | J:352709
 
First Author: Neubert NJ
Year: 2018
Journal: Sci Transl Med
Title: T cell-induced CSF1 promotes melanoma resistance to PD1 blockade.
Volume: 10
Issue: 436
•
•
•
•
•
Publication
23563312 | J:201460
First Author: Hanna SC
Year: 2013
Journal: J Clin Invest
Title: HIF1Ī± and HIF2Ī± independently activate SRC to promote melanoma metastases.
Volume: 123
Issue: 5
Pages: 2078-93
•
•
•
•
•
Publication
35561684 | J:325979
First Author: Choi YS
Year: 2022
Journal: Cell
Title: Topical therapy for regression and melanoma prevention of congenital giant nevi.
Volume: 185
Issue: 12
Pages: 2071-2085.e12
•
•
•
•
•
Strain
MGI:5752238 | B6J.Cg-Tg(Tyr-cre/ERT2)13Bos Nras<tm1.1Nesh> Cdkn2a<tm2.1Nesh> Stk11<tm1.1Rdp>
Attribute String: transgenic, targeted mutation, mutant strain, congenic
•
•
•
•
•
Publication
24003131 | J:201160
First Author: Ni TK
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: Low-copy piggyBac transposon mutagenesis in mice identifies genes driving melanoma.
Volume: 110
Issue: 38
Pages: E3640-9
•
•
•
•
•
Publication
35768444 | J:326521
First Author: Vittoria MA
Year: 2022
Journal: Nat Commun
Title: Inactivation of the Hippo tumor suppressor pathway promotes melanoma.
Volume: 13
Issue: 1
Pages: 3732
•
•
•
•
•
Publication
24200692 | J:207627
First Author: Marsh Durban V
Year: 2013
Journal: J Clin Invest
Title: Differential AKT dependency displayed by mouse models of BRAFV600E-initiated melanoma.
Volume: 123
Issue: 12
Pages: 5104-18
•
•
•
•
•
Publication
36368445 | J:332391
     
First Author: Dong B
Year: 2022
Journal: J Invest Dermatol
Title: FZD6 Promotes Melanoma Cell Invasion but Not Proliferation by Regulating Canonical Wnt Signaling and Epithelialā€’Mesenchymal Transition.
•
•
•
•
•
Publication
29180473 | J:256302
First Author: Brighton HE
Year: 2018
Journal: Cancer Res
Title: New Mechanisms of Resistance to MEK Inhibitors in Melanoma Revealed by Intravital Imaging.
Volume: 78
Issue: 2
Pages: 542-557
•
•
•
•
•
Publication
25472943 | J:221978
First Author: Deuker MM
Year: 2015
Journal: Cancer Discov
Title: PI3'-kinase inhibition forestalls the onset of MEK1/2 inhibitor resistance in BRAF-mutated melanoma.
Volume: 5
Issue: 2
Pages: 143-53
•
•
•
•
•
Publication
24736544 | J:212454
First Author: Ho PC
Year: 2014
Journal: Cancer Res
Title: Immune-based antitumor effects of BRAF inhibitors rely on signaling by CD40L and IFNĪ³.
Volume: 74
Issue: 12
Pages: 3205-17
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom